about
The TECH@HOME study, a technological intervention to reduce caregiver burden for informal caregivers of people with dementia: study protocol for a randomized controlled trialReduced cerebrospinal fluid concentration of interleukin-12/23 subunit p40 in patients with cognitive impairment.Detailed comparison of amyloid PET and CSF biomarkers for identifying early Alzheimer diseaseCerebrospinal fluid (CSF) 25-hydroxyvitamin D concentration and CSF acetylcholinesterase activity are reduced in patients with Alzheimer's disease.The amyloid-β degradation pattern in plasma--a possible tool for clinical trials in Alzheimer's disease.Increased cerebrospinal fluid soluble TREM2 concentration in Alzheimer's disease.Increased Cerebrospinal Fluid Levels of Ubiquitin Carboxyl-Terminal Hydrolase L1 in Patients with Alzheimer's Disease.A targeted proteomic multiplex CSF assay identifies increased malate dehydrogenase and other neurodegenerative biomarkers in individuals with Alzheimer's disease pathology.Psychometric testing of a Swedish version of the Apathy Evaluation Scale.Converging pathways of chromogranin and amyloid metabolism in the brain.The ELISA-measured increase in cerebrospinal fluid tau that discriminates Alzheimer's disease from other neurodegenerative disorders is not attributable to differential recognition of tau assembly forms.Reduced Cerebrospinal Fluid Concentration of Apolipoprotein A-I in Patients with Alzheimer's Disease.Reduced cerebrospinal fluid level of thyroxine in patients with Alzheimer's disease.Cerebrospinal Fluid Stanniocalcin-1 as a Biomarker for Alzheimer's Disease and Other Neurodegenerative Disorders.Cognitive medicine - a new approach in health care science.Pro-inflammatory S100A9 Protein as a Robust Biomarker Differentiating Early Stages of Cognitive Impairment in Alzheimer's Disease.Leukocyte telomere length (LTL) is reduced in stable mild cognitive impairment but low LTL is not associated with conversion to Alzheimer's disease: a pilot study.Cerebrospinal fluid biomarkers for Alzheimer’s disease: diagnostic performance in a homogeneous mono-center population.Cerebrospinal fluid substance P concentrations are elevated in patients with Alzheimer's disease.Increased Cerebrospinal Fluid Level of Insulin-like Growth Factor-II in Male Patients with Alzheimer's Disease.Cerebrospinal fluid microglial markers in Alzheimer's disease: elevated chitotriosidase activity but lack of diagnostic utility.Serum but not cerebrospinal fluid levels of insulin-like growth factor-I (IGF-I) and IGF-binding protein-3 (IGFBP-3) are increased in Alzheimer's diseaseMild dementia is associated with increased adrenal secretion of cortisol and precursor sex steroids in womenThe MS4A gene cluster is a key modulator of soluble TREM2 and Alzheimer's disease risk
P50
Q30363309-B50579CA-61C8-45D0-A370-8078326EE2BFQ33626656-3DBDFE7A-0768-4006-AF5A-4FB51A8B9CBDQ34493453-10BDFEBF-45A4-4E56-A93D-AFE114733AFEQ35060833-8615AF2D-3449-4A28-A129-5B84DE11CFBDQ35162995-564E2505-7C33-4439-B92D-91893B6F2F6FQ36454535-858828B3-06A8-4DA6-8073-840C76C56A2BQ37136770-05A2FFA5-4EB3-465C-8AAC-ED2089C320E4Q37648226-6085AC15-AEDF-473D-AE65-D3E4D9AE6E1EQ38717457-DF475695-9BCE-4C0C-9A9A-D241E6374218Q39711622-BF53CBC8-C232-409D-9167-067ECB85C2F2Q45764162-5DA7A34F-44A4-4BBE-BF68-2D2B42A7BCC8Q47670919-C9BF10BA-BE14-4A93-86C4-C27DFA5DAD91Q48292097-7A7AF18C-6598-41CD-A06D-AE36E85C54CAQ48504522-FC798C03-2DDF-4AC1-834E-821D13C9FB3CQ49779453-9424842E-6EB1-456F-9F02-1D95A688ACF9Q50777223-97401E62-21DB-436E-8F39-7903760FDD3DQ50975482-257C608B-F65F-46FD-971D-2792519A86B4Q51020848-20793E0B-154E-43B5-A391-365E802FE24FQ52148170-FCB76718-FBE2-4CEA-807A-3D1B72103FC7Q52148895-D09ECDEE-E6DD-4378-AFB0-BAB6F94CDC4AQ53319037-FB95D940-84A8-4AB7-B482-18CE52158F94Q57675752-4DF3BFFC-05AC-4928-9FEF-FA10B4EDEBE7Q57675795-F7FB9197-28F4-4063-96AE-97045AD194C8Q92623376-28EC0B4E-A853-4E2E-BFC9-348579B427F0
P50
description
Zweeds onderzoeker
@nl
researcher ORCID: 0000-0003-0073-7654
@en
name
Per Johansson
@ast
Per Johansson
@en
Per Johansson
@es
Per Johansson
@nl
Per Johansson
@sl
type
label
Per Johansson
@ast
Per Johansson
@en
Per Johansson
@es
Per Johansson
@nl
Per Johansson
@sl
prefLabel
Per Johansson
@ast
Per Johansson
@en
Per Johansson
@es
Per Johansson
@nl
Per Johansson
@sl
P1053
K-3961-2012
P106
P1153
36573616800
P21
P27
P31
P3829
P496
0000-0003-0073-7654